Centro de Investigación del Maule - Talca
Centro de investigación con mas de 20 años de experiencia, con decenas de estudios clínicos realizados , especialmente en el área respiratoriaCalle 30 Ote. 1562, of 701, 3460000 Talca, Maule, Chile
Websitehttp://www.cimtalca.cl
Select an option
I am a doctor
I am a sponsor
Specializations
Colitis ulcerosa
Neumología
Our team
Medical staff
Hernan Araya Moya
Paula Ruiz
Paulina Rojas
Cecilia Reyes Garrido
Absalon Rafael Silva Orellana
Carolina Paz Gonzalez Navarro
Open studies
Pulmonary fibrosis
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Moonscape - Genentech, Inc.See more
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis - Bristol-Myers SquibbSee more
Clinical trial: A treatment for Progressive Pulmonary Fibrosis is being investigated
- Bristol-Myers SquibbSee more
Asthma
Breast Cancer
Study of Belzutifan (MK-6482) Plus Fulvestrant for ER+/HER2- Metastatic Breast Cancer (MK-6482-029/LITESPARK-029) - MK-6482-029 LITESPARK-029 - Merck Sharp & Dohme LLCSee more
Cardiovascular disease
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Head and neck cancer
Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma - STELLAR-305 - ExelixisSee more
Hypercholesterolemia
Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes - CORALreef Outcomes - MK-0616-015 - Merck Sharp & Dohme LLCSee more
Lung cancer
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) - CodeBreaK 202 - AmgenSee more
Rare diseases
A Study Evaluating the Efficacy and Safety of Vixarelimab in Participants With Idiopathic Pulmonary Fibrosis and in Participants With Systemic Sclerosis-Associated Interstitial Lung Disease - Moonscape - Genentech, Inc.See more
